Tuesday, February 22, 2005 (9:00 - 10:15 a.m.) Clopton Auditorium
"From Receptors to Response
Thoughts on Mechanism of Antipsychotics"
Shitji Kapur, M.D., Ph.D., F.R.C.P.C.
Vice President, Research Canadian Research Center
Professor of Psychiatry, University of Toronto,
Center for Addiction and Mental Health
Supported by: Astra Zeneca, Bristol-Myers Squibb, GlaxoSmith Kline,
Janssen Pharmaceutica and Wyeth Pharmaceuticals
February 23, 2005 (1:30 - 2:30 p.m.) East Pavilion Auditorium
PLEASE NOTE THE CHANGE IN TIME FOR THE RESEARCH SEMINAR
THE SEMINAR WILL BEGIN AT 1:30 THIS WEEK ONLY.
"Neurotoxicity Induced by NMDA Antagonism:
Effects of Age and Species"
Nuri B. Farber, M.D.
TUESDAY RESIDENT SEMINAR:
February 22, 2005 (10:30 a.m.) 3rd Floor Conference Room
THEME: Psychiatric Disorders-Benchside to Bedside:
"Alcoholism, Genetics & Epidemiology"
Danielle Dick, Ph.D.
WEDNESDAY ADVANCED RESIDENT SEMINAR:
February 23, 2005 (9:00 - 10:30 a.m.) 3rd Floor Conference Room
THEME: Family therapy and other Psychotherapeutic Topics
Mark Johnson, M.D.
Monday, February 21, 2005 (1:00-2:00 p.m.) Suite 4 conference room,
Parc Frontenac, 40 North Kingshighway
Coursemaster: Renee M. Cunningham-Williams
"Recent Advances in Treating Substance Use as a Chronic Condition"
Michael L. Dennis, Ph.D.
Chestnut Health Systems, Bloomington, Illionois
DEPARTMENTS OF NEUROLOGY & NEUROLOGICAL SURGERY RESEARCH SEMINAR:
Monday, February 21, 2005 (12:00 noon), Schwarz Auditorium
TO BE ANNOUNCED